Advertisement

Topics

Complement Genomics Company Profile

12:35 EST 13th December 2018 | BioPortfolio

We also provide a walk-in service for the North of England which includes Northumberland, Tyne & Wear, County Durham, Teeside, Yorkshire and Cumbria. Our laboratories are easily
accessible and are located in Sunderland which is not too far away from all the local major
areas including Durham, Newcastle, Middlesbrough, Hartlepool, Leeds, York, Harrogate,
Carlisle, Darlington, Doncaster and Hexham.

Contact

Phone: 44 (0)191 5166500
Email: sales@dadcheck.com


News Articles [440 Associated News Articles listed on BioPortfolio]

Alexion, Complement co-develop CP010 for neurodegenerative disorders; Alexion has option to acquire company

Alexion Pharmaceuticals Inc. and Complement Pharma are collaborating on the development of Complement's CP010 for neurodegenerative disorders.

Alexion, Complement to develop neurodegenerative disease candidate

Alexion signed a deal with Complement Pharma that aims to develop the latter's preclinical complement 6 inhibitor CP010 under -More- 

Alexion and Complement Pharma Partner to Develop Complement Inhibitor for Neurodegenerative Disorders

NEW HAVEN, Conn., & AMSTERDAM–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Complement Pharma today announced a partnership to co-develop the preclinical C6 complemen...

Alexion goes back to roots with Complement deal

Alexion has made a lot of money from investing in the science behind complement inhibitors – C5 inhibitor, Soliris, has been a huge earner for the company. Now, the company has decided to return to ...

10X Genomics Prepares to Hire 200 New Employees, Move into Larger Facility

Bay Area-based genomics company 10X Genomics has become one of the fastest growing privately-held companies in the region with an earnings increase of more than 2,000 percent over a three-year period.

Microsoft Genomics Ventures into the Microbiome With Eagle Genomics

LONDON, October 15, 2018 /PRNewswire/ -- Cambridge technology innovators partner with Microsoft Genomics Microbiomic research into immune disorders and antibiotic resistance First microbiome partn...

Festival of Genomics London 2018: the landmark event making genomics mainstream

London, UK, 5th January 2018 / Sciad Newswire / This January sees the third edition of Festival of Genomics London, the largest meeting of its kind in the UK. Following two US editions of the event ...

QUANTUM GENOMICS: Quantum Genomics receives ethics committee approval to initiate clinical study of extended-release firibastat tablets

Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat hypertension and h...

Drugs and Medications [0 Results]

None

PubMed Articles [262 Associated PubMed Articles listed on BioPortfolio]

Is Early Complement Activation in Renal Transplantation Associated with Later Graft Outcome?

Complement activation is important in post-transplantation renal injury, but data on its role as predictor of transplant outcome/complications when assessed in donor kidneys are lacking.

Bacterial Autophagy: How to Take a Complement.

Complement, a complex system of serum proteins, contributes to host defense through multiple mechanisms. In this issue of Cell Host & Microbe, Sorbara et al. (2018) discovered that cytosolic pathogen...

Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR.

Single-cell genomics.

Complement receptor 1 (CR1, CD35) association with susceptibility to leprosy.

Pathophysiological mechanisms are still incompletely understood for leprosy, an urgent public health issue in Brazil. Complement receptor 1 (CR1) binds complement fragments C3b/C4b deposited on mycoba...

Clinical Trials [131 Associated Clinical Trials listed on BioPortfolio]

First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers

Safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of a Single Ascending Dose (SAD) and a Multiple Dose (MD) of the complement inhibitor AMY-101. A prospective, single-c...

Complement Diagnosis of Acute Appendicitis

Acute appendicitis is a common condition requiring urgent surgery but is often difficult to distinguish from other non-surgical conditions such as urinary infections, pelvic inflammatory d...

The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in Children

Vasculitis denotes affection of small to medium sized vessels by polyangitis. Antineutrophil cytoplasmic antibodies (ANCA) are immunoglobulin G (IgG) autoantibodies directed against consti...

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Companies [430 Associated Companies listed on BioPortfolio]

Complement Genomics

We also provide a walk-in service for the North of England which includes Northumberland, Tyne & Wear, County Durham, Teeside, Yorkshire and Cumbria. Our laboratories are easily accessible and are loc...

True North Therapeutics, Inc.

True North Therapeutics is a biotechnology company developing novel therapies that selectively target the Complement pathway of the immune system to address fundamental mechanisms...

True North Therapeutics

True North Therapeutics is a biotechnology company developing novel therapies that selectively target the Complement pathway of the immune system to address fundamental mechanisms...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

More Information about "Complement Genomics" on BioPortfolio

We have published hundreds of Complement Genomics news stories on BioPortfolio along with dozens of Complement Genomics Clinical Trials and PubMed Articles about Complement Genomics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Complement Genomics Companies in our database. You can also find out about relevant Complement Genomics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record